- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07636993
Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis
Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis (Clinical and Laboratory Study)
I) Patients:
The present study will be carried on periodontitis patients. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University.
Groups:
Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.
Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).
Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).
Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:
- Plaque index (PI).(15)
- Gingival index.(16)
- Probing pocket depth (PPD).(17)
- Clinical attachment level (CAL).(18) B) Gingival crevicular fluid sampling. C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.
B) Immunological analysis of TNF-α in GCF
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
I) Patients:
The present study will be carried on periodontitis patients. The patient will be selected from Out Patient Clinic, Department of Oral Medicine, Periodontology, Diagnosis and Oral Radiology, Faculty of Dentistry, Mansoura University. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University. The patients must be legally competent to provide written consent before performing any required steps.
A)Inclusion Criteria
- Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
- Minimum of 20 remaining teeth.
- Age range (25 - 50) years.
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program. B) Exclusion Criteria
1. Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
2. Receiving periodontal therapy in past 6 month. 3. Pregnant and lactating females. 4. Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).
5. Smoking.
D) Groups:
Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.
Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).
Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).
II) Clinical Procedures:
- Medical and dental histories will be taken from patients.
- Mechanical debridement will be performed using suitable ultrasonic and hand instruments for positive control and study groups.
A) Periodontal assessment:
Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:
- Plaque index (PI).(15)
- Gingival index.(16)
- Probing pocket depth (PPD).(17)
- Clinical attachment level (CAL).(18)
B) Gingival crevicular fluid sampling. The GCF samples will be collected from all subjects at baseline and three months after treatment.(19)
C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.
III) Laboratory procedures
A) Pharmaceutics Section: Formulation development:
Sunflower oil and derevatives:
The study will involve using sunflower oil as pure form and/or ozonated using controlled conditions. The oils will be used in preparation of gel formulation for applications in the mouth cavity using different formulation techniques.
- Development of Formulations:
Based on the oil formulation, various gels will be developed with a focus on creating formulations suitable for clinical application.
- Different gel bases will be evaluated to optimize their physicochemical characteristics.
- Physicochemical Parameters of the gel formulations will be assessed to ensure the desired properties.
- The developed gels will undergo in-vitro testing under different conditions.
- Once optimized, the selected gel formulation(s) will be prepared for testing in clinical trials.
B) Immunological analysis of TNF-α in GCF
Assessment of crevicular fluid TNF-α will be performed using enzyme-linked immunosorbent assay technique
Type d'étude
Inscription (Réel)
Phase
- Première phase 1
Contacts et emplacements
Lieux d'étude
-
-
-
Al Mansurah, Egypte
- Mansoura University, faculty of dentistry
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
- Minimum of 20 remaining teeth.
- Age range (25 - 50) years.
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program.
Exclusion Criteria:
- Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
- Receiving periodontal therapy in past 6 month.
- Pregnant and lactating females.
- Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).
- Smoking.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Autre: positive control group
control recived mechanical debridment only
|
mechanical debridment
|
|
Aucune intervention: negative control
healthy
|
|
|
Expérimental: study group A
sunflower seed oil gel for each pocket
|
patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket
|
|
Expérimental: study group B
Ozonated Sunflower Oil
|
patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
assess the clinical effectiveness of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement in stage II grade B periodontitis
Délai: 3 month
|
1) Plaque Index: deposits were recorded the level of oral hygiene.The percentage of all tooth surfaces that showed the presence of plaque was determined by recording the full-mouth plaque score dichotomously (presence/absence of plaque) on six different points per tooth.The frequency of positive surfaces was given in percentages relative to the total number of tested surfaces.
2) Gingival index: 0 = Normal gingiva.1=Slight
inflammation.2
= Moderate glazing.
3 = Severe.
3) Probing pocket depth:For each group, the PPD was measured from the base of the pocket on the whole mouth to the free gingival margin.4)
Clinical attachment level:It is the space between the base of the periodontal pocket and CEJ.
Six locations were used to measure the clinical attachment loss: three on the facial surface and three on the lingual or palatal surface.5)
Bleeding on probing:take the percentage from all teeth that appear BOP
|
3 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
assess the impact of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement on the GCF level of TNF-α in stage II periodontitis
Délai: 3 months
|
GCF sample will be assessed for TNF-α.
TNF-α. is an inflammatory mediator.
Assessment of gingival crevicular fluid(GCF) TNF-α will be performed using enzyme-linked immunosorbent assay technique.
|
3 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ahmed Hashem Alshareef, Bachelors degree, Mansoura University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- M04020250M
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .